From pressure overload to volume overload: Aortic regurgitation after transcatheter aortic valve implantation

American Heart Journal

Volumn 163, Issue 6, 2012, Pages 903-911

  Gotzmann, Michael ^a   Lindstaedt, Michael ^a   Mügge, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; AORTA BALLOON; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; CALCIFICATION; CARDIAC PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE OVERLOAD; HEMODYNAMICS; HUMAN; INTERMETHOD COMPARISON; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STARR EDWARDS VALVE PROSTHESIS; SURGICAL PATIENT; SURGICAL RISK; SURVIVAL; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VALVULOPLASTY;

AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BALLOON DILATION; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PREVALENCE; VENTRICULAR PRESSURE;

EID: 84862533949     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.03.017     Document Type: Review

References (70)

1. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011;8:162-72.
2. Ross Jr J, Braunwald E. Aortic stenosis. Circulation 1968;38:61-7.
3. Bonow RO, Carabello BA, Chatterjee K, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-142.
4. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20. (Pubitemid 41746694)
5. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8. (Pubitemid 35440280)
6. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
7. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
8. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63. (Pubitemid 47255993)
9. Buellesfeld L, Gerckens U, Schuler G, et al. 2-Year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 2011;57:1650-7.
10. Gotzmann M, Bojara W, Lindstaedt M, et al. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol 2011;107:1687-92.
11. Gotzmann M, Pljakic A, Bojara W, et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J 2011;162:238-45.e1.
12. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009;53:1883-91.
13. Jilaihawi H, Chin D, Spyt T, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-CoreValve bioprosthesis. Eur Heart J 2010;31:857-64.
14. Gotzmann M, Lindstaedt M, Bojara W, et al. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J 2010;159:926-32.
15. Carabello BA. Aortic regurgitation. A lesion with similarities to both aortic stenosis and mitral regurgitation. Circulation 1990;82:1051-3. (Pubitemid 20316760)
16. Goldbarg SH, Halperin JL. Aortic regurgitation: disease progression and management. Nat Clin Pract Cardiovasc Med 2008;5:269-79. (Pubitemid 351605835)
17. Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation 2005;112:125-34 Erratum in: Circulation. 2005;112:e124.
18. Stout KK, Verrier ED. Acute valvular regurgitation. Circulation 2009;119:3232-41.
19. Otto CM, Bonow RO. Aortic stenosis. In: Libby P, Bonow RO, Mann DL, Zipes DP, editors. Braunwald's heart disease. 8th ed. Philadelphia: WB Saunders; 2008. p. 1626-8.
20. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009;373:956-66.
21. Chambers J, Monaghan M, Jackson G. Colour flow Doppler mapping in the assessment of prosthetic valve regurgitation. Br Heart J 1989;62:1-8. (Pubitemid 19171228)
22. Rallidis LS, Moyssakis IE, Ikonomidis I, et al. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J 1999;138:351-7. (Pubitemid 29379690)
23. O'Rourke DJ, Palac RT, Malenka DJ, et al. Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography. J Am Coll Cardiol 2001;38:163-6. (Pubitemid 32613844)
24. Ionescu A, Fraser AG, Butchart EG. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography. Heart 2003;89:1316-21. (Pubitemid 37311094)
25. Dávila-Román VG, Waggoner AD, Kennard ED, et al, Artificial Valve Endocarditis Reduction Trial echocardiography study. Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study. J Am Coll Cardiol 2004;44:1467-72. (Pubitemid 39303950)
26. Cribier A, Savin T, Berland J, et al. Percutaneous transluminal balloon valvuloplasty of adult aortic stenosis: report of 92 cases. J Am Coll Cardiol 1987;9:381-6. (Pubitemid 17013802)
27. Nishimura RA, Holmes Jr DR, Reeder GS, et al. Doppler evaluation of results of percutaneous aortic balloon valvuloplasty in calcific aortic stenosis. Circulation 1988;78:791-9.
28. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995;26:1522-8.
29. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703. (Pubitemid 38229547)
30. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
31. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009;53:1829-36.
32. Lefèvre T, Kappetein AP, Wolner E, et al, PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011;32:148-57.
33. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
34. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
35. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
36. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve Revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
37. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011;32:191-7.
38. Zahn R, Gerckens U, Grube E, et al. German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011;32:198-204.
39. Moat NE, Ludman P, Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8.
40. Ussia GP, Mulè M, Barbanti M, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009;30: 1790-6.
41. Gotzmann M, Hehen T, Germing A, et al. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart 2010;96:1102-6.
42. Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010;122:1319-27.
43. Walther T, Thielmann M, Kempfert J, et al. PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II). Eur J Cardiothorac Surg 2012 [Epub ahead of print].
44. Abdel-Wahab M, Zahn R, Horack M, et al, for the German Transcatheter Aortic Valve Interventions Registry Investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 2011;97:899-906.
45. Cheng A, Dagum P, Miller DC. Aortic root dynamics and surgery: from craft to science. Philos Trans R Soc Lond B Biol Sci 2007;362:1407-19. (Pubitemid 47195031)
46. Piazza N, de Jaegere P, Schultz C, et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 2008;1:74-81 Erratum in: Circ Cardiovasc Interv. 2008;1:e1.
47. Ho SY. Structure and anatomy of the aortic root. Eur J Echocardiogr 2009;10:i3-10.
48. Schultz CJ, Moelker A, Piazza N, et al. Three dimensional evaluation of the aortic annulus using multislice computer tomography: are manufacturer's guidelines for sizing for percutaneous aortic valve replacement helpful? Eur Heart J 2010;31:849-56.
49. Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2008;1:321-30. (Pubitemid 351681425)
50. Schultz CJ, Weustink A, Piazza N, et al. Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. J Am Coll Cardiol 2009;54:911-8.
51. Delgado V, Ng AC, van de Veire NR, et al. Transcatheter aortic valve implantation: role of multi-detector row computed tomography to evaluate prosthesis positioning and deployment in relation to valve function. Eur Heart J 2010;31:1114-23.
52. Détaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2009;2:821-7.
53. Takagi K, Latib A, Al-Lamee R, et al. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after corevalve implantation and the impact of postdilatation. Catheter Cardiovasc Interv 2011;78:432-43.
54. Zahn R, Schiele R, Kilkowski C, et al. Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol 2010;99:193-7.
55. Muñoz-García AJ, Alonso-Briales JH, Jiménez-Navarro MF, et al. Mechanisms, treatment and course of paravalvular aortic regurgitation after percutaneous implantation of the CoreValve aortic prosthesis. Int J Cardiol 2011;149:389-92.
56. Ussia GP, Barbanti M, Immè S, et al. Management of implant failure during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010;76:440-9.
57. Ewe SH, Ng AC, Schuijf JD, et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol 2011;108:1470-7.
58. Clavel MA, Dumont E, Pibarot P, et al. Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann Thorac Surg 2009;87:618-21.
59. Gotzmann M, Mügge A. Fatal prosthetic valve endocarditis of the CoreValve ReValving System. Clin Res Cardiol 2011;100:715-7.
60. Sellers RD, Levy Mj, Amplatz K, et al. Left retrograde cardioangiography in acquired cardiac disease: technic, indications and interpretations in 700 cases. Am J Cardiol 1964;14:437-47.
61. Zoghbi WA, Chambers JB, Dumesnil JG, et al American Society of Echocardiography's Guidelines and Standards Committee, Task Force on Prosthetic Valves, American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, European Association of Echocardiography, European Society of Cardiology, Japanese Society of Echocardiography, Canadian Society of Echocardiography, American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, European Society of Cardiology, Japanese Society of Echocardiography, Canadian Society of Echocardiography. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009;22:975-1014.
62. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-69.
63. Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011;32:2189-214.
64. Gonçalves A, Almeria C, Marcos-Alberca P, et al. Three-dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation. J Am Soc Echocardiogr 2012;25:47-55.
65. Sherif MA, Abdel-Wahab M, Beurich HW, et al. Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. EuroIntervention 2011;7:57-63.
66. Messika-Zeitoun D, Serfaty JM, Brochet E, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010;55:186-94.
67. Koos R, Altiok E, Mahnken AH, et al. Evaluation of aortic root for definition of prosthesis size by magnetic resonance imaging and cardiac computed tomography: Implications for transcatheter aortic valve implantation. Int J Cardiol 2011 [Epub ahead of print].
68. Leipsic J, Gurvitch R, Labounty TM, et al. Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging 2011;4:416-29.
69. Sherif MA, Abdel-Wahab M, Stöcker B, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 2010;56:1623-9.
70. Rodés-Cabau J, Dumont E, Doyle D. "Valve-in-valve" for the treatment of paravalvular leaks following transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2009;74:1116-9.